Shareholder Votes

Pluri Inc. shareholders voted on Election of Directors at the 2026-06-15 meeting.

“Proposal No. 1 - Election of Directors The shareholders cast the following votes for the following individuals nominated as directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified. Director Name For Against Abstain Broker Non-Votes Alexandre Weinstein 6,467,999 33,238 16,135 1,063,825 Eitan Ajchenbaum 2,830,098 3,668,436 18,838 1,063,825 Rami Levi 6,480,813 20,891 15,668 1,063,825 Maital Shemesh-Rasmussen 6,486,725 20,843 9,804 1,063,825 Yaky Yanay 6,466,339 48,768 2,265 1,063,825”

ArriVent BioPharma, Inc. shareholders approved Auditor Ratification at the 2026-06-18 meeting.

“2. Auditor Ratification Shares Voted For Shares Voted Against Shares Abstaining Broker Non-votes 33,411,773 829 6,191 0”

ArriVent BioPharma, Inc. shareholders approved Election of Directors at the 2026-06-18 meeting.

“1. Election of Directors Nominee Shares Voted For Shares Voted to Withhold Authority Broker Non-votes James Healy, M.D., Ph.D. 18,058,285 11,527,650 3,832,858 John Hohneker, M.D. 28,043,164 1,542,771 3,832,858 Stuart Lutzker, M.D., Ph.D. 29,495,923 90,012 3,832,858”

UNIVERSAL DISPLAY CORP PA shareholders approved Proposal to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2026 at the 2026-06-18 meeting.

“3. Proposal to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2026 . Votes FOR Votes AGAINST Abstentions Broker Non-Votes 41,561,564 981,659 38,018 n/a * Abstentions were not considered votes “cast” on this proposal.”

UNIVERSAL DISPLAY CORP PA shareholders approved Advisory resolution to approve compensation of the Company’s named executive officers at the 2026-06-18 meeting.

“2. Advisory resolution to approve compensation of the Company’s named executive officers . Votes FOR Votes AGAINST Abstentions Broker Non-Votes 30,833,842 7,506,813 69,399 4,171,187 * Abstentions and broker non-votes were not considered votes “cast” on this proposal.”

UNIVERSAL DISPLAY CORP PA shareholders approved Election of Directors at the 2026-06-18 meeting.

“1. Election of Directors . Name Votes FOR Votes AGAINST Abstentions Broker Non-Votes Steven V. Abramson 37,862,560 514,598 32,896 4,171,187 Nigel Brown 38,048,461 322,239 39,354 4,171,187 Cynthia J. Comparin 37,091,401 1,282,325 36,328 4,171,187 Richard C. Elias 37,363,539 1,008,128 38,387 4,171,187 Elizabeth H. Gemmill 35,335,378 3,043,479 31,197 4,171,187 C. Keith Hartley 35,831,460 2,540,787 37,807 4,171,187 Celia M. Joseph 34,242,750 4,135,503 31,801 4,171,187 Lawrence Lacerte 35,090,435 3,280,656 38,963 4,171,187 Joan Lau 37,537,209 836,890 35,955 4,171,187 Sidney D. Rosenblatt 37,398,294 977,519 34,241 4,171,187 April Walker 38,220,756 156,183 33,115 4,171,187 * Abstentions and broker non-votes were not considered votes “cast” with respect to the election of directors.”

Alaska Silver Corp. shareholders approved Issuance of common shares to insiders in settlement of debts at the 2026-06-19 meeting.

“Proposal No. 5: The Company's disinterested shareholders approved the issuance of common shares of the Company to certain insiders of the Company in settlement of outstanding debts owed by the Company to such insiders, as more fully set forth in the management information circular of the Company dated May 19, 2026, as follows: Votes For Votes Against 14,201,471 145,945”

Alaska Silver Corp. shareholders approved Approval of 10% rolling Long Term Incentive Plan and amendments at the 2026-06-19 meeting.

“Proposal No. 4: The Company's shareholders approved the Company's 10% rolling Long Term Incentive Plan and certain amendments thereto, as follows: Votes For Votes Against 25,655,086 1,289,493”

Alaska Silver Corp. shareholders approved Re-appointment of Auditor Davidson & Company LLP at the 2026-06-19 meeting.

“Proposal No. 3: The Company's shareholders approved the re-appointment of the Company's current auditor, Davidson & Company LLP, for the fiscal year ending December 31, 2026 at a remuneration to be fixed by the directors, as follows : Votes For Votes Withheld 26,896,549 48,030”

Alaska Silver Corp. shareholders approved Election of six directors at the 2026-06-19 meeting.

“Proposal No. 2: The Company's shareholders elected six directors, to hold office until the Company's 2027 annual general shareholders meeting, or until his or her successor is duly elected and qualified, subject to prior death, resignation or removal, as follows: Name of Director Votes For Withhold Christopher Marrs 25,658,403 1,286,176 Nathan Brewer 24,516,340 2,428,239 David Smallhouse 24,507,340 2,437,239 Kevin Nishi 24,507,340 2,437,239 Susan Mitchell 25,728,736 1,215,843 Aaron Schutt 25,707,253 1,237,326”

Alaska Silver Corp. shareholders approved Setting the number of directors to be elected at six at the 2026-06-19 meeting.

“Proposal No. 1: The Company's shareholders approved the setting of the number of directors to be elected at the Meeting at six, as follows : Votes For Votes Against 26,881,474 63,105”

Greenland Mines Ltd shareholders approved Approval of one or more amendments to the Certificate of Incorporation to effect reverse stock splits with exchange ratios between 1-for-2 and 1-for-50 at the 2026-06-18 meeting.

“Set forth below are the final voting results for the Reverse Stock Split Proposal. Proposal 1. Approval of the Reverse Stock Split. For Against Abstain Broker Non-Votes 42,878,771 2,210,259 22,102 0”

SYPRIS SOLUTIONS INC shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2026-06-16 meeting.

“The stockholders of the Company approved an advisory resolution approving the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 30, 2026 (the “Proxy Statement”). The following is a breakdown of the voting results: FOR AGAINST ABSTAIN BROKER NON-VOTES 12,687,835 154,456 13,664 0”

SYPRIS SOLUTIONS INC shareholders approved Election of Class III directors at the 2026-06-16 meeting.

“The stockholders of the Company elected each of the Class III director nominees proposed by the Company’s Board of Directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified. The following is a breakdown of the voting results: DIRECTOR FOR WITHHELD BROKER NON-VOTES William G. Ferko 12,560,502 295,453 0 Jeffrey T. Gill 12,805,569 50,386 0”

PROVECTUS BIOPHARMACEUTICALS, INC. shareholders approved Authorization to amend Certificate of Incorporation to decrease authorized shares of common and preferred stock by the reverse stock split ratio at the 2026-06-18 meeting.

“Proposal 5 . The Company’s stockholders authorized the Board, given the Company’s stockholders’ approval of Proposal 4, to amend the Company’s Certificate of Incorporation, as amended by the Certificates of Designation, to decrease the number of authorized shares of the Company’s common stock and preferred stock by the same reverse stock split ratio determined by the Board, consistent with the Board’s recommendation. There were no broker non-votes with respect to the proposal. Number of Votes For 311,771,119 Against 22,227,876 Abstention 5,831,898”

PROVECTUS BIOPHARMACEUTICALS, INC. shareholders approved Authorization to amend Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-10 and 1-for-50 at the 2026-06-18 meeting.

“Proposal 4 . The Company’s stockholders authorized the Board to amend the Company’s Certificate of Incorporation, as amended by the Certificate of Designation of Series D Convertible Preferred Stock and Certificate of Designation of Series D-1 Convertible Preferred Stock (the “Certificates of Designation”), to effect a reverse stock split of the Company’s common stock, Series D Convertible Preferred Stock, and Series D-1 Convertible Preferred Stock at a ratio of between 1-for-10 and 1-for-50, where the ratio would be determined by the Board at its discretion, and to make corresponding amendments to the Certificates of Designation to provide for the proportional adjustment of certain terms upon a reverse stock split, consistent with the Board’s recommendation. There were no broker non-votes with respect to the proposal. Number of Votes For 315,344,309 Against 23,622,833 Abstention 863,751”

PROVECTUS BIOPHARMACEUTICALS, INC. shareholders approved Ratification of selection of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for 2026 at the 2026-06-18 meeting.

“Proposal 3 . The Company’s stockholders ratified the selection of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for 2026, consistent with the Board’s recommendation. There were no broker non-votes with respect to the proposal. Number of Votes For 329,742,597 Against 7,6914,122 Abstention 2,474,174”

PROVECTUS BIOPHARMACEUTICALS, INC. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2026-06-18 meeting.

“Proposal 2 . The Company’s stockholders approved the advisory vote on the compensation of the Company’s named executive officers, consistent with the Board’s recommendation. There were 131,619,889 broker non-votes with respect to the proposal. Number of Votes For 190,162,705 Against 16,667,960 Abstention 1,380,339”

PROVECTUS BIOPHARMACEUTICALS, INC. shareholders approved Election of Directors at the 2026-06-18 meeting.

“Proposal 1 . The Company’s stockholders elected the following directors for a term of one-year, consistent with the recommendation of the Company’s board of directors (the “Board”). There were 131,619,889 broker non-votes with respect to the proposal. Name of Candidate Number of Votes For Withhold Authority Webster Bailey 191,823,174 16,387,830 John Lacey, III, M.D. 191,947,635 16,263,369 Ed Pershing, CPA 197,553,672 10,657,332 Dominic Rodrigues 192,036,957 16,174,047”

SOUTH DAKOTA SOYBEAN PROCESSORS LLC shareholders approved Election of three members to the board of managers at the 2026-06-16 meeting.

“On the proposal to elect three members to the board of managers, the following persons were elected: District 1: Brandon Hope District 2: Spencer Enninga District 3: Adam Schindler”

Innventure, Inc. shareholders approved To ratify the appointment of Withum Smith+Brown, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-17 meeting.

“Proposal 2 : To ratify the appointment of Withum Smith+Brown, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The ratification was approved by vote of stockholders as follows: Votes For Votes Against Abstentions 53,604,019 50,044 252,733”

Innventure, Inc. shareholders approved To elect three nominees to serve as Class II directors for a three-year term expiring at the 2029 annual meeting of stockholders. at the 2026-06-17 meeting.

“The voting results were as follows: Director Nominee Votes For Votes Withheld Broker Non-Votes Bruce Brown 31,623,445 3,658,598 18,624,753 James O. Donnally 32,998,141 2,293,902 18,624,753 Catriona Fallon 35,074,494 207,549 18,624,753”

DYADIC INTERNATIONAL INC shareholders approved Advisory vote on compensation of the Company’s named executive officers as described in the Proxy Statement. at the 2026-06-18 meeting.

“Proposal 4: Advisory vote on compensation of the Company’s named executive officers as described in the Proxy Statement. For Against Abstained Broker Non-Votes 18,213,001 343,799 739,157 10,313,240”

DYADIC INTERNATIONAL INC shareholders approved Ratification of appointment of Crowe LLP as the Company’s independent registered public accounting firm for the current fiscal year ending December 31, 2026. at the 2026-06-18 meeting.

“Proposal 3: Ratification of appointment of Crowe LLP as the Company’s independent registered public accounting firm for the current fiscal year ending December 31, 2026. For Against Abstained 28,623,686 517,907 467,604”

DYADIC INTERNATIONAL INC shareholders approved To approve the board of directors’ authorization to effect, at its discretion, a reverse stock split of the Company’s common stock, by a ratio in the range set forth in the Company’s Definitive Proxy Statement on Schedule 14A relating to the 2026 Annual Meeting (the “Proxy Statement”). at the 2026-06-18 meeting.

“Proposal 2: To approve the board of directors’ authorization to effect, at its discretion, a reverse stock split of the Company’s common stock, by a ratio in the range set forth in the Company’s Definitive Proxy Statement on Schedule 14A relating to the 2026 Annual Meeting (the “Proxy Statement”). For Against Abstained 25,419,068 3,725,962 464,167”

DYADIC INTERNATIONAL INC shareholders approved Election of Class I director to serve until the Company’s 2029 Annual Meeting of Shareholders. at the 2026-06-18 meeting.

“Proposal 1: Election of Class I director to serve until the Company’s 2029 Annual Meeting of Shareholders. Nominee For Withheld Broker Non-Votes Seth J. Herbst, M.D 18,121,850 1,174,107 10,313,240”

Capstone Holding Corp. shareholders approved Adjournment of Annual Meeting at the 2026-06-18 meeting.

“6. The proposal of the adjournment of the Annual Meeting was approved as follows: Votes For ​ ​ Votes Against ​ ​ Broker Non-Votes ​ ​ Votes Abstained ​ 8,569,818 ​ ​ ​ 1,035,346 ​ ​ ​ 0 ​ ​ ​ 493,534 ​”

Capstone Holding Corp. shareholders approved Amendment to Capstone Holding Corp. 2025 Stock Incentive Plan to increase maximum aggregate shares from 21.5% to 35% at the 2026-06-18 meeting.

“5. The proposal of an amendment to the Capstone Holding Corp. 2025 Stock Incentive Plan (the “ First Amendment to the Capstone Holding Corp. 2025 Stock Incentive Plan ”) to increase the maximum aggregate number of shares available for awards from 21.5% of the number of Common Shares outstanding as of the first trading day of each quarter to 35% of the number of Common Shares outstanding as of the first trading day of each quarter was approved as follows: Votes For ​ ​ Votes Against ​ ​ Broker Non-Votes ​ ​ Votes Abstained ​ 7,309,819 ​ ​ ​ 1,081,988 ​ ​ ​ 1,696,914 ​ ​ ​ 9,977 ​”

Capstone Holding Corp. shareholders approved Amendment to Certificate of Incorporation to effect reverse stock split at ratio not less than 1-for-5 and not more than 1-for-50 at the 2026-06-18 meeting.

“4. The proposal of an amendment to the Certificate of Incorporation to effect a reverse stock split of the Company’s common stock at a ratio of not less than 1-for-5 and not more than 1-for-50, with the exact ratio and timing to be determined by the Board of Directors in its discretion within twelve months of stockholder approval was approved as follows: Votes For ​ ​ Votes Against ​ ​ Broker Non-Votes ​ ​ Votes Abstained ​ 8,171,581 ​ ​ ​ 1,923,132 ​ ​ ​ 0 ​ ​ ​ 3,985 ​”

Capstone Holding Corp. shareholders approved Ratification of appointment of GBQ Partners LLC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-18 meeting.

“3. The proposal to ratify the appointment of GBQ Partners LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as follows: Votes For ​ ​ Votes Against ​ ​ Broker Non-Votes ​ ​ Votes Abstained ​ 9,425,270 ​ ​ ​ 302,428 ​ ​ ​ 0 ​ ​ ​ 371,000 ​”

Capstone Holding Corp. shareholders approved Election of Class II directors at the 2026-06-18 meeting.

“2. The two nominees for Class II director were elected to serve a two-year term as follows: Director ​ Votes For ​ ​ % Votes For ​ ​ Votes Withheld ​ ​ % Votes Withheld ​ John M. Holliman, III ​ ​ 7,892,856 ​ ​ ​ 93.94 % ​ ​ 508,928 ​ ​ ​ 6.06 % Gordon Strout ​ ​ 7,889,264 ​ ​ ​ 93.90 % ​ ​ 512,520 ​ ​ ​ 6.10 %”

Capstone Holding Corp. shareholders approved Election of Class I directors at the 2026-06-18 meeting.

“1. The two nominees for Class I director were elected to serve a one-year term as follows: Director ​ Votes For ​ ​ % Votes For ​ ​ Votes Withheld ​ ​ % Votes Withheld ​ Fredric J. Feldman, Ph.D. ​ ​ 7,903,599 ​ ​ ​ 94.07 % ​ ​ 498,185 ​ ​ ​ 5.93 % Elwood D. Howse, Jr. ​ ​ 7,893,504 ​ ​ ​ 93.95 % ​ ​ 508,280 ​ ​ ​ 6.05 %”

LIFETIME BRANDS, INC shareholders approved Advisory approval of the 2025 compensation of named executive officers.

“Proposal 3 The Company’s stockholders voted to approve, on an advisory, non-binding basis, the 2025 compensation of the Company’s named executive officers, based on the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 15,747,252 65,124 322,022 4,529,514”

LIFETIME BRANDS, INC shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-12-31 meeting.

“Proposal 2 The Company’s stockholders voted to ratify the appointment of Ernst & Young LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, based on the following votes: FOR AGAINST ABSTAIN BROKER NON-VOTES 20,397,055 157,901 108,956 0”

LIFETIME BRANDS, INC shareholders approved Election of nine directors to serve until the 2027 Annual Meeting.

“Proposal 1 The Company’s stockholders elected each of the following nine (9) nominees unanimously recommended by the Board, each of whom were named in the Proxy Statement, to serve on the Board to hold office until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified, based on the following votes: FOR WITHHELD ABSTAIN BROKER NON-VOTES Jeffrey Siegel 13,617,253 2,515,911 1,234 4,529,514 Robert B. Kay 15,051,616 1,081,549 1,233 4,529,514 Jeffrey H. Evans 15,057,303 1,075,862 1,233 4,529,514 Rachael A. Jarosh 15,028,730 1,105,195 473 4,529,514 Cherrie Nanninga 14,002,619 2,131,306 473 4,529,514 Bruce G. Pollack 14,620,592 1,512,573 1,233 4,529,514 Michael J. Regan 14,040,509 2,092,656 1,233 4,529,514 Michael Schnabel 15,027,990 1,105,175 1,233 4,529,514 Daniel Siegel 14,995,177 1,137,988 1,233 4,529,514”

Revolution Medicines, Inc. shareholders approved Non-binding advisory approval of named executive officer compensation at the 2026-06-18 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes 155,110,825 5,554,146 176,733 20,813,641”

Revolution Medicines, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-18 meeting.

“Votes For Votes Against Abstentions 181,309,783 206,306 139,256”

Revolution Medicines, Inc. shareholders approved Election of two Class III directors to hold office until the 2029 annual meeting at the 2026-06-18 meeting.

“Nominee Votes For Votes Withheld Broker Non-Votes Alexis Borisy 127,181,172 33,660,532 20,813,641 Mark A. Goldsmith, M.D., Ph.D. 157,681,628 3,160,076 20,813,641”

HARROW, INC. shareholders approved Ratification of Auditors at the 2026-06-18 meeting.

“Proposal 3: Ratification of Auditors Stockholders ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the voting were: For Against Abstain Broker Non-Vote 28,578,182 1,249,248 3,543”

HARROW, INC. shareholders approved To approve on an advisory basis, the compensation of the Company’s named executive officers at the 2026-06-18 meeting.

“Proposal 2: To approve on an advisory basis, the compensation of the Company’s named executive officers Stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers. The results of the voting were: For Against Abstain Broker Non-Vote 18,065,856 2,395,240 502,679 8,867,198”

HARROW, INC. shareholders approved Election of Directors at the 2026-06-18 meeting.

“Proposal 1: Election of Directors Stockholders voted to elect to the Board of Directors the four (4) director nominees named in the Company’s proxy statement to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified. The results of the voting were: Directors For Withheld Broker Non-Vote Mark L. Baum 18,733,392 2,230,383 8,867,198 Adrienne L. Graves 19,375,636 1,588,139 8,867,198 Lauren P. Silvernail 19,423,429 1,540,346 8,867,198 Perry J. Sternberg 19,427,617 1,536,158 8,867,198”

EyePoint, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm Deloitte & Touche LLP at the 2026-04-21 meeting.

“Proposal No. 4. Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting on this proposal is set forth below:”

EyePoint, Inc. shareholders approved Non-Binding Advisory Vote on Named Executive Officer Compensation at the 2026-04-21 meeting.

“Proposal No. 3. Non-Binding Advisory Vote on Named Executive Officer Compensation The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The voting on this proposal is set forth below:”

EyePoint, Inc. shareholders approved Amendment to 2023 Long-Term Incentive Plan to increase the number of shares of Common Stock authorized for issuance thereunder by 4,900,000 shares at the 2026-04-21 meeting.

“Proposal No. 2. Amendment to 2023 Long-Term Incentive Plan The Company’s stockholders approved the 2023 Plan Amendment to increase the number of shares of Common Stock authorized for issuance thereunder by 4,900,000 shares. The voting on this proposal is set forth below:”

EyePoint, Inc. shareholders approved Election of Directors at the 2026-04-21 meeting.

“Proposal No. 1. Election of Directors The Company’s stockholders elected the following directors to the Board, each to serve until the Company’s 2027 Annual Meeting of Stockholders and until such person’s successor is duly elected and qualified. The voting on this proposal is set forth below:”

Bio Green Med Solution, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2025-06-18 meeting.

“Approval by an Advisory Vote the Executive Compensation. Our shareholders approved, by an advisory vote, the compensation of our named executive officers and directors, as disclosed in this proxy statement.”

Bio Green Med Solution, Inc. shareholders approved Approval of the Appointment of Auditors at the 2025-06-18 meeting.

“Our shareholders ratified the appointment of SFAI Malaysia Plt. (PCAOB: 7167), as our independent auditors for the 2026 fiscal year ending December 31, 2026.”

Bio Green Med Solution, Inc. shareholders approved Election of Class I Directors at the 2025-06-18 meeting.

“Election of Directors : Our shareholders voted to elect the following individuals as Class I Directors, each of whom has been approved for re-election for a three-year term expiring at the 2029 annual meeting of stockholders: (a) Dr. Satis Waran Nair Krishnan, and (b) Inigo Angel Laurduraj.”

WIDEPOINT CORP shareholders approved Ratification of appointment of Baker Tilly US, LLP as independent accountants for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

“For Against Abstain Broker Non-Votes 5,985,455 528,398 71,677 -”

WIDEPOINT CORP shareholders approved Election of Class II director at the 2026-06-17 meeting.

“Nominee For Withheld Broker Non-Votes Phil Garfinkle 2,627,323 1,728,442 2,229,765”